Please assess the completion status of the following clinical trial:

Trial Title: L-Arginine and Antioxidant Vitamins During Pregnancy to Reduce Preeclampsia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Previous pregnancy complicated with pre-eclampsia/eclampsia~* Singleton pregnancy~* Gestational age \>20 weeks \<34 weeks~* Protein excretion \< 300 mg/day~Exclusion Criteria:~* Multiple gestation~* Major fetal anomaly~* Pre-existing hypertension~* Pre-existing renal disease~* Diabetes~* Collagen vascular disease~* Cancer or strong family history of cancer in first degree relatives~* Preexisting maternal disease requiring medication

- Gender: FEMALE
- Minimum Age: 19 Years
- Maximum Age: 32 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).